Relief Therapeutics

Supporting patients through science and innovation

Financial information

Investors interested in Relief Therapeutics may contact

Dr. Raghuram (Ram) Selvaraju at:
investors@relieftherapeutics.com

Relief Therapeutics Holding AG is listed on the SIX Swiss Exchange under the valor symbol RLF.
Share details
Valor number10’019’113
Regulatory standardInternational Reporting Standard
Trading currencyCHF
Nominal share value0,01
Share capital (in units)1'946'627'375
Authorized capital (in units)925’000’000
Conditional capital (in units)925’000’000
General meetings
Last general meeting25 May 2016
Next general meetingto be decided
AuditorsPriceWaterhouseCoopers
Principal shareholders
GEM Global Yield Fund
Fin Posillipo SpA
Relief founders
Pierrel SpA

Disclosure of Shareholdings
Shareholders who hold shares in a company incorporated in Switzerland whose equity securities are listed in Switzerland have the duty to disclose if they reach, exceed or fall below certain thresholds (3, 5, 10, 15, 20, 25, 33 1/3, 50, 66 2/3 % of voting rights.)
Please inform us in case of exceedance or shortfall of the threshold by post or e-mail with the official term “Disclosure of Shareholdings”. 
The reporting form can be found at this link: www.autoneum.com